The protective effects of Ninjin’yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse

被引：0
|
作者：
Kyohei Takano
Marisa Kaneda
Yayoi Aoki
Nina Fujita
Shigeki Chiba
Seiwa Michihara
Li-Kun Han
Ryuji Takahashi
机构：
[1] Kracie,Kampo Research Laboratory, Pharmaceutical Company
[2] Ltd.,undefined
来源：
Journal of Natural Medicines | 2024年 / 78卷
关键词：
Ninjin’yoeito; Steatosis; Fibrosis; Non-alcoholic steatohepatitis; Choline-deficient L-amino acid-defined high-fat diet;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：514 / 524
页数：10
相关论文
共 50 条
  • [1] The protective effects of Ninjin'yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse
    Takano, Kyohei
    Kaneda, Marisa
    Aoki, Yayoi
    Fujita, Nina
    Chiba, Shigeki
    Michihara, Seiwa
    Han, Li-Kun
    Takahashi, Ryuji
    JOURNAL OF NATURAL MEDICINES, 2024, 78 (03) : 514 - 524
  • [2] Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis
    Sugino, Haruko
    Kumagai, Naoki
    Watanabe, Sakiko
    Toda, Kyoko
    Takeuchi, Osamu
    Tsunematsu, Satoshi
    Morinaga, Shojiroh
    Tsuchimoto, Kanji
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (12) : 1909 - 1916
  • [3] Combination effects of alogliptin and pioglitazone on steatosis and hepatic fibrosis formation in a mouse model of non-alcoholic steatohepatitis
    Amano, Yuichiro
    Tsuchiya, Shuntarou
    Imai, Mayumi
    Tohyama, Kimio
    Matsukawa, Jun
    Isono, Osamu
    Yasuno, Hironobu
    Enya, Kazuaki
    Koumura, Emiko
    Nagabukuro, Hiroshi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 497 (01) : 207 - 213
  • [4] Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of non-alcoholic steatohepatitis
    Kobayashi, Tomoki
    Kanno, Keishi
    Nguyen, Phuong Thao
    Sugiyama, Akiko
    Kawahara, Akihiro
    Otani, Yuichiro
    Kishikawa, Nobusuke
    Ito, Masanori
    Tazuma, Susumu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (12) : 2140 - 2150
  • [5] Effects of a PEGylated fibroblast growth factor 21 variant on steatosis, inflammation, and fibrosis in a mouse model of non-alcoholic steatohepatitis
    Zinker, B.
    Boehm, S.
    Gao, S.
    He, A.
    Strassle, B.
    Morin, P.
    Christian, R.
    Krupinski, J.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S390 - S390
  • [6] Pitavastatin inhibits hepatic steatosis and fibrosis in non-alcoholic steatohepatitis model rats
    Miyaki, Tomokatsu
    Nojiri, Shunsuke
    Shinkai, Noboru
    Kusakabe, Atsunori
    Matsuura, Kentaro
    Iio, Etsuko
    Takahashi, Satoru
    Yan, Ge
    Ikeda, Kazuo
    Joh, Takashi
    HEPATOLOGY RESEARCH, 2011, 41 (04) : 375 - 385
  • [7] Microbial DNA enrichment promotes liver steatosis and fibrosis in the course of non-alcoholic steatohepatitis
    Luo, Zhenlong
    Ji, Yudong
    Zhang, Dinghong
    Gao, Hong
    Jin, Zhongmou
    Yang, Meixiang
    Ying, Wei
    ACTA PHYSIOLOGICA, 2022, 235 (03)
  • [8] A mouse model for Non-alcoholic Steatohepatitis
    Sundaresan, Sinju
    Vijayagopal, Parakat
    Mills, Nathaniel
    Imrhan, Victorine
    Prasad, Chandan
    FASEB JOURNAL, 2010, 24
  • [9] Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis
    Thomas Klein
    Masato Fujii
    Jan Sandel
    Yuichiro Shibazaki
    Kyoko Wakamatsu
    Michael Mark
    Hiroyuki Yoneyama
    Medical Molecular Morphology, 2014, 47 : 137 - 149
  • [10] Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis
    Klein, Thomas
    Fujii, Masato
    Sandel, Jan
    Shibazaki, Yuichiro
    Wakamatsu, Kyoko
    Mark, Michael
    Yoneyama, Hiroyuki
    MEDICAL MOLECULAR MORPHOLOGY, 2014, 47 (03) : 137 - 149
12345